Consolidated Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Operating Activities:
Net loss	$ 4,344,424	$ (18,834,126)	$ (38,728,066)	$ (49,246,355)
Adjustments to reconcile net loss to net cash provided from (used for) operating activities:
Depreciation and amortization			649,343	537,826
Provision for uncollectible accounts	5,679,953	10,456,447	24,036,357	32,880,630	$ 52,621,682
Provision for other uncollectible receivables			6,833,033	4,428,035
Equity based compensation and restricted stock vested			8,204,894	10,726,825
Amortization of debt issuance costs			821,770	500,202
Impairment losses on long-lived assets			26,109	5,474
Loss on extinguishment of line of credit	0	0	0	1,092,679
Changes in operating assets and liabilities:
Notes receivable			17,155,162	(65,794,390)
Other receivables			(4,103,107)	(4,486,106)
Prepaid expenses and other assets			(307,559)	(3,297,530)
Merchant accounts payable			(12,171,770)	29,848,199
Other payables			2,361,293	2,135,408
Accrued liabilities			1,750,462	9,456,969
Deferred revenue			531,092	0
Operating leases			12,107	(30,832)
Net Cash Provided from (Used for) Operating Activities			7,071,120	(31,242,966)
Investing Activities:
Purchase of property and equipment			(12,404)	(559,502)
Internally developed intangible asset additions			(774,139)	(515,023)
Net Cash Used for Investing Activities			(786,543)	(1,074,525)
Financing Activities:
Payments on long term debt			0	(1,220,332)
Proceeds from line of credit			5,000,000	67,666,667
Payments to line of credit			(29,791,614)	(102,666,667)
Payments of debt issuance costs			(60,853)	(1,698,190)
Payment of debt extinguishment costs			0	(1,000,000)
Proceeds from stock option exercises			99,738	411,422
Stock subscriptions collected related to stock option exercises			324,378	208,578
Repurchase of common stock			(349,203)	(1,829,725)
Proceeds from issuance of common stock			0	30,000,000
Costs incurred from issuance of common stock			0	2,768
Net Cash Used for Financing Activities			(24,777,554)	(10,131,015)
Effect of exchange rate changes on cash			(1,632,131)	239,519
Net decrease in cash, cash equivalents, and restricted cash			(18,492,977)	(42,448,506)
Cash, cash equivalents, and restricted cash, beginning of year			78,890,168	89,103,903	89,103,903
Cash, cash equivalents, and restricted cash, end of period	$ 58,765,060	$ 46,894,916	58,765,060	46,894,916	$ 78,890,168
Noncash investing and financing activities:
Lease liabilities arising from obtaining right-of-use assets			0	142,597
Conversion of liability-classified incentive awards to stockholder's equity			0	9,293,035
Supplementary disclosures:
Interest paid			4,865,371	3,611,852
Income taxes paid			$ 24,298	$ 4,575